Integrin involvement in glioblastoma multiforme: possible regulation by NF-kappaB

Area of Science:

• Neuro-oncology
• Molecular Biology
• Cell Biology

Background:

• Glioblastoma multiforme (GBM) is a highly aggressive brain tumor known for its invasive nature.
• Tumor cell interaction with the extracellular matrix (ECM) is crucial for tumorigenesis and invasion.
• The role of specific transcription factors in regulating these interactions is not fully understood.

Purpose of the Study:

• To investigate the role of the nuclear transcription factor NF-kappaB in regulating integrin expression and cell attachment in GBM.
• To elucidate the mechanisms by which NF-kappaB influences GBM cell adhesion to ECM components.

Main Methods:

• Utilized GBM cell lines (SNB-19, T98G) and normal astrocytes.
• Stimulated NF-kappaB activation using PMA (phorbol 12-myristate 13-acetate).
• Assessed gene expression of ECM proteins (fibronectin, vitronectin) and integrin subunits (beta3, alphav) using quantitative methods.
• Quantified cell attachment to ECM proteins and evaluated the effect of RGD peptide.

Main Results:

• PMA treatment increased fibronectin and vitronectin gene expression in GBM cells.
• Overexpression of NF-kappaB subunits elevated fibronectin gene expression.
• GBM cell attachment to fibronectin and vitronectin was enhanced by PMA, unlike normal astrocytes.
• RGD peptide significantly inhibited GBM cell attachment to fibronectin and vitronectin.
• NF-kappaB activation led to increased mRNA levels for beta3 and alphav integrin subunits.

Conclusions:

• NF-kappaB plays a significant role in regulating ECM gene expression in glioblastoma.
• Activation of NF-kappaB enhances GBM cell adhesion to ECM proteins, potentially via integrin modulation.
• These findings suggest NF-kappaB is a potential therapeutic target for inhibiting glioma cell invasion.